TIGIT and neoplasm: LAG-3 is highly co-expressed with other immune inhibitory molecules, including TIM-3, PD-1, 2B4 and T-cell immunoglobulin and ITIM domain (TIGIT), on tumor-specific CD4+ effector T cells [163].